Based on these findings, we explored the therapeutic rescue of experimental stroke in mice using an inhibitor of the vascular endothelial protein tyrosine phosphatase (VE-PTP), a pivotal negative regulator of Tie2 signaling [54]. Here, PTPRB is linked to stroke disorder.